Skip to main content
VREOF
OTC Life Sciences

Vireo Growth Completes Acquisition of Hawthorne Gardening, Secures $110M in Capital and Board Seat for ScottsMiracle-Gro EVP

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.428
Mkt Cap
$461.893M
52W Low
$0.315
52W High
$0.8
52W Position info
36% above low
Off High info
47% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

VREOF sits 36% above its 52-week low of $0.315.

Summary

Vireo Growth Inc. has completed the acquisition of The Hawthorne Gardening Company, a leading provider of indoor gardening supplies, in exchange for 213 million shares and 80 million warrants, significantly boosting its balance sheet and market presence.


Key Events · M&A and Partnerships · VREOF

  • Acquisition Completion

    Vireo Growth Inc. completed the acquisition of The Hawthorne Gardening Company LLC, a leading provider of indoor and hydroponic gardening supplies, from The Scotts Miracle-Gro Company.

  • Capital Injection

    The acquisition brings approximately $110 million in combined cash and net working capital to Vireo's balance sheet.

  • Equity Consideration

    Vireo issued 213 million subordinate voting shares at a deemed value of $0.60 per share and 80 million warrants with an exercise price of $0.85 per share to Good Dog Holdings LLC (Scotts' designee).

  • Board Representation

    Chris Hagedorn, Executive Vice President of The Scotts Miracle-Gro Company, has been nominated for election to Vireo's Board of Directors, signaling a strategic partnership.


Analysis · VREOF · Life Sciences

This acquisition is a major strategic move for Vireo Growth, expanding its market footprint in the indoor and hydroponic gardening sector through the integration of Hawthorne Gardening, a leading provider. The transaction injects approximately $110 million in combined cash and net working capital into Vireo's balance sheet, providing substantial capital for a company of its size. While the issuance of 213 million shares immediately, and potentially another 80 million shares through warrants, represents significant dilution (approximately 16.9% immediately and up to 23.2% potentially), the strategic benefits, including a strengthened balance sheet and a partnership with ScottsMiracle-Gro (evidenced by the board nomination of Chris Hagedorn), are highly impactful. The lock-up agreement for the issued shares indicates a long-term commitment from the seller.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VREOF was trading at $0.43 on OTC in the Life Sciences sector, with a market capitalization of approximately $461.9M. The 52-week trading range was $0.31 to $0.80. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREOF - Latest Insights

VREOF
Nov 17, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.95
Real-time Price: $5.35 info
Change: -$0.603472 (-10%) info
Market Cap: $312.827M info
VREOF
Nov 16, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.29
Real-time Price: $5.35 info
Change: -$0.940 (-15%) info
Market Cap: $312.827M info
VREOF
Nov 12, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.76
Real-time Price: $5.35 info
Change: -$1.41 (-21%) info
Market Cap: $312.827M info
VREOF
Nov 10, 2026, 4:05 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.68
Real-time Price: $5.35 info
Change: -$1.33 (-20%) info
Market Cap: $312.827M info
VREOF
Nov 10, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.78
Real-time Price: $5.35 info
Change: -$1.43 (-21%) info
Market Cap: $312.827M info